Table 3.

Activity of cholesteryl ester transfer protein (CETP) compared with Systematic Coronary Risk Evaluation (SCORE) risk levels. No patient from the glucocorticoid-naive group fulfilled the definition for very high SCORE risk. CEPT activity expressed as median (25th–75th percentile) pmol/3 h.

SCORE Risk CategoryLinear Trend
CETP ActivitynLow RisknModerate RisknHigh RisknVery High Riskß (95% CI)p*
Controls6249.2 (36.9–61.3)4234.6 (26.0–53.5)631.9 (21.8–42.9)58.7 (1.5–15.8)−9.3 (−14.8 – 3.7)0.00
RA patients5138.3 (27.9–50.0)3126.8 (20.5–45.2)1522.3 (16.2–44.3)417.7 (13.3–22.1)−4.7 (−9.3 – 0.2)0.04
GC-negative RA patients3238.8 (30.4–50.7)928.4 (24.6–55.4)520.3 (16.5–39.6)0−4.9 (−11.2 – 0.8)0.04
GC-positive RA patients1937.8 (24.7–45.7)2221.9 (17.1–39.7)1016.3 (9.9–19.3)417.7 (13.3–22.1)−5.7 (−10.8 – 0.5)0.03
  • * p value refers to a trend analysis model considering independent variable (SCORE risk) as orthogonal polynomials. GC: glucocorticoid; RA: rheumatoid arthritis.